Diabetes screening in older adults is the use of blood-glucose tests to identify type 2 diabetes or prediabetes before symptoms become obvious. The American Diabetes Association (ADA) recommends testing adults beginning at age 35 and repeating testing at least every three years when results are normal, while the U.S. Preventive Services Task Force (USPSTF) recommends screening adults ages 35 to 70 who have overweight or obesity. Because diabetes risk rises with age, screening should also account for blood pressure, cholesterol, family history, cardiovascular disease, kidney disease, medications, and functional health. The Centers for Disease Control and Prevention (CDC) estimates that about 38.4 million people in the United States had diabetes in 2021, including approximately 9.7 million cases that were undiagnosed, while 97.6 million adults had prediabetes.
Older-Adult Diabetes Screening Guidelines and Risk Assessment
Older-adult diabetes screening guidelines are evidence-based recommendations for deciding who should receive testing, which blood test to use, and how often results should be reassessed. They apply mainly to type 2 diabetes and prediabetes, which can develop gradually without noticeable symptoms. Screening is different from diagnostic testing: screening identifies people who may have the condition, whereas a confirmed diagnosis generally requires a qualifying result that is repeated or verified with another test.
The USPSTF defines screening as testing people without recognized symptoms to detect disease early enough for treatment to improve health outcomes. Its recommendation applies to adults ages 35 to 70 with overweight or obesity and assigns the recommendation a “B” grade, meaning there is high certainty of a moderate benefit or moderate certainty of a moderate-to-substantial benefit. The ADA uses a broader approach, recommending testing for all adults beginning at age 35 and earlier testing for people with additional risk factors.
Routine screening for adults age 65 and older
Routine screening means checking an older adult who does not have a confirmed diabetes diagnosis, even when symptoms are absent. Adults age 65 and older generally meet the ADA’s age-based testing recommendation. A primary-care clinician may order an A1C test, fasting plasma glucose test, or oral glucose tolerance test depending on medical history, symptoms, and the need for a convenient or highly sensitive assessment.
A normal result does not permanently eliminate risk. The ADA states that people with normal results should generally be retested at least every three years, with more frequent testing when risk factors change. For an older adult with prediabetes, yearly testing is commonly appropriate, although the clinician may choose a different interval based on the result, health status, and treatment plan.
Risk-based screening beyond age alone
Risk-based screening adds testing for people whose medical or social characteristics increase the likelihood of abnormal glucose levels. Important risk factors include:
- Overweight or obesity, particularly increased abdominal fat.
- A parent, sibling, or child with type 2 diabetes.
- High blood pressure, abnormal cholesterol levels, cardiovascular disease, or a history of stroke.
- Physical inactivity, obstructive sleep apnea, or fatty liver disease.
- A history of gestational diabetes or giving birth to a large infant.
- Use of medicines that can raise glucose, including long-term glucocorticoids and some antipsychotic medications.
- Higher-risk ethnic or racial backgrounds, including Black, Hispanic or Latino, American Indian or Alaska Native, Native Hawaiian, and Pacific Islander populations.
The CDC reports that age, family history, overweight, and physical inactivity are among the major contributors to type 2 diabetes risk. In older adults, risk assessment should also consider frailty, cognitive impairment, life expectancy, and whether detecting a mild glucose abnormality would change care. Screening remains useful, but the purpose should be prevention and informed treatment rather than applying identical targets to every person.
Older-Adult Diabetes Screening Tests and Diagnostic Thresholds
Diabetes screening tests measure blood glucose directly or estimate average glucose exposure over time. The ADA, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and USPSTF recognize A1C, fasting plasma glucose, and the 2-hour oral glucose tolerance test as standard options. Point-of-care tests may be useful in some clinical settings, but abnormal results typically require confirmation with a laboratory-based test.
A1C test
The A1C test estimates average blood glucose during approximately the previous two to three months by measuring the proportion of hemoglobin with glucose attached to it. It does not require fasting, which makes it convenient for many older adults and caregivers. An A1C below 5.7% is generally considered normal, 5.7% to 6.4% indicates prediabetes, and 6.5% or higher is in the diabetes range.
A1C can be misleading when red blood cell survival is altered. Clinicians should interpret it carefully in people with anemia, recent blood loss or transfusion, hemoglobin variants, advanced kidney disease, or certain blood disorders. If the A1C conflicts with symptoms or a glucose result, a fasting or oral glucose test may provide a clearer answer.
Fasting plasma glucose
Fasting plasma glucose measures blood glucose after at least eight hours without caloric food or drink. A result below 100 milligrams per deciliter is generally normal, 100 to 125 milligrams per deciliter indicates impaired fasting glucose or prediabetes, and 126 milligrams per deciliter or higher is in the diabetes range. Water is usually permitted during the fasting period, but the testing laboratory’s instructions should be followed.
This test is relatively inexpensive and widely available, but illness, stress, poor sleep, and some medications can temporarily affect glucose. A single high result does not always establish a diagnosis in a person without classic symptoms.
Oral glucose tolerance test and random glucose
The 2-hour oral glucose tolerance test measures glucose after fasting and again two hours after drinking a standardized glucose solution. A 2-hour result of 140 to 199 milligrams per deciliter indicates impaired glucose tolerance, while 200 milligrams per deciliter or higher is in the diabetes range. Although this test can detect abnormalities that fasting glucose misses, it requires several hours and may be less practical for an older person with mobility, transportation, or fasting difficulties.
A random plasma glucose test can be used when symptoms are present. A result of 200 milligrams per deciliter or higher, together with classic symptoms such as excessive thirst, frequent urination, unexplained weight loss, or blurred vision, may support a diabetes diagnosis. Healthcare professionals determine whether confirmation is needed.
Older-Adult Diabetes Screening Intervals and Follow-Up
Screening intervals are the planned periods between tests after considering the most recent result and the person’s risk profile. They should not be confused with home glucose monitoring, which is used after diabetes has been diagnosed or when a clinician is evaluating symptoms or medication effects.
When results are normal
For an older adult with a normal A1C or glucose result and no major change in health, repeat screening at least every three years is consistent with ADA guidance. Earlier testing may be reasonable after substantial weight gain, reduced activity, initiation of a glucose-raising medicine, a new cardiovascular condition, or symptoms suggestive of hyperglycemia.
When results show prediabetes
Prediabetes means glucose is higher than normal but below the usual diabetes threshold. It is not inevitable that prediabetes will progress to diabetes, but it signals elevated cardiometabolic risk. The CDC’s National Diabetes Prevention Program emphasizes weight management, increased physical activity, and healthy eating as effective strategies for reducing progression risk. In the original Diabetes Prevention Program trial, intensive lifestyle intervention reduced the incidence of type 2 diabetes by 58% over about three years; among adults age 60 and older, the reduction was approximately 71%.
Adults with prediabetes should usually receive repeat glucose testing at least annually, along with a discussion of nutrition, physical activity, sleep, medication effects, and cardiovascular risk. Referral to a recognized diabetes prevention program can provide structured support. Metformin may be considered for selected high-risk individuals, although age, kidney function, frailty, gastrointestinal tolerance, and overall treatment goals must be reviewed.
When results are in the diabetes range
A diabetes-range result generally requires confirmation on a separate day or by another accepted test when the person does not have unequivocal symptoms. Confirmation prevents a temporary stress-related or laboratory-related elevation from being treated as a permanent diagnosis. If symptoms are severe or glucose is markedly elevated, prompt clinical evaluation is important.
After diagnosis, care extends beyond glucose testing. Clinicians commonly assess blood pressure, cholesterol, kidney function, urine albumin, eye health, foot health, dental health, vaccination status, and cardiovascular risk. Medicare covers certain diabetes screening services for eligible beneficiaries, and coverage details may depend on the person’s plan and documented risk factors.
Older-Adult Diabetes Screening in the Context of Healthy Aging
Healthy-aging screening balances early detection with the person’s goals, independence, and ability to benefit from treatment. Diabetes can contribute to heart disease, stroke, kidney disease, vision loss, nerve damage, falls, infections, and delayed wound healing, so identifying it can lead to meaningful prevention. At the same time, an older adult with advanced illness or limited life expectancy may need a more individualized approach to testing and follow-up.
Symptoms that should prompt evaluation
Screening guidelines apply to people without clear symptoms, but symptoms should prompt medical evaluation rather than waiting for the next routine test. Warning signs include frequent urination, unusual thirst or hunger, unexplained weight loss, fatigue, recurrent infections, slow-healing cuts, blurred vision, numbness, or tingling. Older adults may have few symptoms, and changes in cognition, balance, hydration, or continence can have many causes, including abnormal glucose.
Medication and kidney-function considerations
Medication review is an essential part of older-adult screening. Steroids can raise blood glucose, while some medicines and kidney problems can increase the risk of low glucose after treatment begins. Kidney function also affects medication selection and the interpretation of some laboratory results. An older adult should not stop or change a prescribed medicine solely because of a screening result without speaking with a healthcare professional.
Individualized care for frailty and cognitive impairment
For a frail adult or someone with dementia, screening decisions should include the person, family members or caregivers when appropriate, and the clinical team. The benefits of identifying diabetes should be weighed against fasting burdens, transportation challenges, anxiety, competing illnesses, and the likelihood that treatment will improve quality of life. The ADA recommends individualized goals for older adults rather than one universal glucose target.
Practical Diabetes Screening Checklist for Older Adults
An older adult preparing for a primary-care visit can use the following checklist to make screening more effective:
- Ask whether an A1C, fasting glucose, or another test is most appropriate.
- Bring a current list of prescription medicines, over-the-counter products, and supplements.
- Report symptoms, recent weight changes, changes in activity, falls, infections, or vision changes.
- Share family history and any history of gestational diabetes or cardiovascular disease.
- Ask when the result should be repeated and what result requires follow-up.
- If prediabetes is diagnosed, request a specific prevention plan and discuss a recognized lifestyle program.
- Confirm whether Medicare or another insurer covers the recommended test and follow-up services.
A useful visual for patient education is a three-zone chart: normal glucose range, prediabetes range, and diabetes range, with a separate note explaining that confirmation may be required. Such a chart can improve understanding, but it should not replace interpretation by a qualified healthcare professional.
Conclusion: Why Diabetes Screening Matters After Age 65
Older-adult diabetes screening guidelines support routine testing beginning at age 35, risk-based testing at any appropriate age, and repeat evaluation at least every three years when results are normal. A1C, fasting plasma glucose, and the oral glucose tolerance test are the principal screening tools, while prediabetes generally calls for annual monitoring and lifestyle support. Diabetes-range results usually require confirmation, and treatment decisions should account for kidney function, medications, frailty, cognition, life expectancy, and personal goals.
The broader implication is that early detection can reduce preventable complications and create an opportunity for healthier aging, but screening is most valuable when it leads to practical follow-up. Older adults should ask their healthcare professional whether they are due for testing, review their risk factors, and seek prompt evaluation for symptoms rather than waiting for a routine appointment.
Sources: American Diabetes Association, Standards of Care in Diabetes—2026, https://diabetesjournals.org/care/issue/49/Supplement_1; U.S. Preventive Services Task Force, Screening for Prediabetes and Type 2 Diabetes, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes; Centers for Disease Control and Prevention, National Diabetes Statistics Report, https://www.cdc.gov/diabetes/data-research/research/diabetes-statistics/index.html; National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes Tests and Diagnosis, https://www.niddk.nih.gov/health-information/diagnostic-tests/diabetes; Centers for Disease Control and Prevention, National Diabetes Prevention Program, https://www.cdc.gov/diabetes-prevention/; Centers for Medicare & Medicaid Services, Diabetes Screening Coverage, https://www.medicare.gov/coverage/diabetes-screenings; Diabetes Prevention Program Research Group, Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin, New England Journal of Medicine, https://www.nejm.org/doi/full/10.1056/NEJMoa012512
